{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:10:49Z","timestamp":1790935849473,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1602\/neurorx.1.2.206","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T22:38:21Z","timestamp":1080686301000},"page":"206-212","source":"Crossref","is-referenced-by-count":47,"title":["Molecular neuroimaging in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"1","author":[{"given":"William","family":"Jagust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10200206_CR1","first-page":"31","volume":"35","author":"SS Kety","year":"1956","unstructured":"Kety SS. Human cerebral blood flow and oxygen consumption as related to aging.Res Publ Assoc Res Nerv Ment Dis 35: 31\u201345, 1956.","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10200206_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/brain\/104.4.753","volume":"104","author":"RSJ Frackowiak","year":"1981","unstructured":"Frackowiak RSJ, Pozzili C, Legg NJ, Du Boulay GH, Marshall J, Lenzi L et al. Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron tomography.Brain 104: 753\u2013778, 1981.","journal-title":"Brain"},{"key":"10200206_CR3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]Fluorodeoxyglucose.J Comput Assist Tomogr 7: 590\u2013598, 1983.","journal-title":"J Comput Assist Tomogr"},{"key":"10200206_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archneur.1983.04050110029003","volume":"40","author":"DF Benson","year":"1983","unstructured":"Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose 18F scan in Alzheimer\u2019s disease and multi-infarct dementia.Arch Neurol 40: 711\u2013714, 1983.","journal-title":"Arch Neurol"},{"key":"10200206_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneur.1987.00520140035014","volume":"44","author":"KA Johnson","year":"1987","unstructured":"Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimer\u2019s disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123.Arch Neurol 44: 165\u2013168, 1987.","journal-title":"Arch Neurol"},{"key":"10200206_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.1987.00520150014011","volume":"44","author":"WJ Jagust","year":"1987","unstructured":"Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography.Arch Neurol 44: 258\u2013262, 1987.","journal-title":"Arch Neurol"},{"key":"10200206_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease.Ann Neurol 42: 85\u201394, 1997.","journal-title":"Ann Neurol"},{"key":"10200206_CR8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archinte.150.4.752","volume":"150","author":"KA Johnson","year":"1990","unstructured":"Johnson KA, Holman BL, Rosen TJ, Nagel JS, English RJ, Growdon JH. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer\u2019s disease.Arch Intern Med 150: 752\u2013756, 1990.","journal-title":"Arch Intern Med"},{"key":"10200206_CR9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0197-4580(92)90076-A","volume":"13","author":"JL Eberling","year":"1992","unstructured":"Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer\u2019s disease.Neurobiol Aging 13: 483\u2013491, 1992.","journal-title":"Neurobiol Aging"},{"key":"10200206_CR10","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.J Nucl Med 36: 1238\u20131248, 1995.","journal-title":"J Nucl Med"},{"key":"10200206_CR11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.50.6.1563","volume":"50","author":"KA Johnson","year":"1998","unstructured":"Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A et al. Preclinical prediction of Alzheimer\u2019s disease using SPECT.Neurology 50: 1563\u20131571, 1998.","journal-title":"Neurology"},{"key":"10200206_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","volume":"17","author":"K Herholz","year":"2003","unstructured":"Herholz K. PET studies in dementia.Ann Nucl Med 17: 79\u201389, 2003.","journal-title":"Ann Nucl Med"},{"key":"10200206_CR13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/WNL.41.9.1374","volume":"41","author":"BL Miller","year":"1991","unstructured":"Miller BL, Cummings JL, Villaneuva-Meyer J, Boone K, Mehringer CM, Lesser IM et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics.Neurology 41: 1374\u20131382, 1991.","journal-title":"Neurology"},{"key":"10200206_CR14","first-page":"1875","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M et al. Cerebral glucose metabolism in patients with frontotemporal dementia.J Nucl Med 39: 1875\u20131878, 1998.","journal-title":"J Nucl Med"},{"key":"10200206_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000052084","volume":"45","author":"P Santens","year":"2001","unstructured":"Santens P, De Bleecker J, Goethals P, Strijckmans K, Lemahieu I, Slegers G et al. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer\u2019s disease and frontotemporal dementia at initial diagnosis.Eur Neurol 45: 19\u201327, 2001.","journal-title":"Eur Neurol"},{"key":"10200206_CR16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","volume":"47","author":"RL Albin","year":"1996","unstructured":"Albin RL, Minoshima S, D\u2019Amato CJ, Frey KA, Kuhl DA, Sima AAF. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease.Neurology 47: 462\u2013466, 1996.","journal-title":"Neurology"},{"key":"10200206_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(97)00713-1","volume":"235","author":"T Imamura","year":"1997","unstructured":"Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer\u2019s disease: a comparative study using positron emission tomography.Neurosci Lett 235: 49\u201352, 1997.","journal-title":"Neurosci Lett"},{"key":"10200206_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","volume":"56","author":"K Lobotesis","year":"2001","unstructured":"Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.Neurology 56: 643\u2013649, 2001.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10200206_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000116474","volume":"29","author":"R Duara","year":"1989","unstructured":"Duara R, Barker W, Loewenstein D, Pascal S, Bowen B. Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer\u2019s disease and multi-infarct dementia.Eur Neurol 29(Suppl 3): 9\u201315, 1989.","journal-title":"Eur Neurol"},{"key":"10200206_CR20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archneur.56.7.809","volume":"56","author":"LT Kwan","year":"1999","unstructured":"Kwan LT, Reed BR, Eberling JL, Schuff N, Tanabe J, Norman D et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function.Arch Neurol 56: 809\u2013814, 1999.","journal-title":"Arch Neurol"},{"key":"10200206_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archneur.1995.00540320049012","volume":"52","author":"DL Sultzer","year":"1995","unstructured":"Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia.Arch Neurol 52: 773\u2013780, 1995.","journal-title":"Arch Neurol"},{"key":"10200206_CR22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410160605","volume":"16","author":"NL Foster","year":"1984","unstructured":"Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ et al. Cortical abnormalities in Alzheimer\u2019s disease.Ann Neurol 16: 649\u2013654, 1984.","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10200206_CR23","first-page":"S99","volume":"14","author":"G Waldemar","year":"1994","unstructured":"Waldemar G, Walovitch RC, Andersen AR, Hasselbalch SG, Bigelow R, Joseph JL et al. 99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial.J Cereb Blood Flow Metab 14(Suppl 1): S99-S105, 1994.","journal-title":"J Cereb Blood Flow Metab"},{"key":"10200206_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000051253","volume":"12","author":"M Kawano","year":"2001","unstructured":"Kawano M, Ichimiya A, Ogomori K, Kuwabara Y, Sasaki M, Yoshida T et al. Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer\u2019s disease: a PET study.Dement Geriatr Cogn Disord 12: 171\u2013176, 2001.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10200206_CR25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","volume":"159","author":"GE Alexander","year":"2002","unstructured":"Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer\u2019s disease treatment studies.Am J Psychiatry 159: 738\u2013745, 2002.","journal-title":"Am J Psychiatry"},{"key":"10200206_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S1041610298005389","volume":"10","author":"KA Jobst","year":"1998","unstructured":"Jobst KA, Barnetson LPD, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer\u2019s disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and ApoE4 in medial temporal lobe dementias.Int Psychogeriatr 10: 271\u2013302, 1998.","journal-title":"Int Psychogeriatr"},{"key":"10200206_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiology.202.3.9051035","volume":"202","author":"FJ Bonte","year":"1997","unstructured":"Bonte FJ, Weiner MF, Bigio EH, White CL. Brian blood flow in the dementias: SPECT with histopathologic correlation in 54 patients.Radiology 202: 793\u2013797, 1997.","journal-title":"Radiology"},{"key":"10200206_CR28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1532-5415.1995.tb07400.x","volume":"43","author":"SL Read","year":"1995","unstructured":"Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia: clinical and pathological correlation.J Am Geriatr Soc 43: 1243\u20131247, 1995.","journal-title":"J Am Geriatr Soc"},{"key":"10200206_CR29","first-page":"1920","volume":"41","author":"JM Hoffman","year":"2000","unstructured":"Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N et al. FDG PET imaging in patients with pathologically verified dementia.J Nucl Med 41: 1920\u20131928, 2000.","journal-title":"J Nucl Med"},{"key":"10200206_CR30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome.JAMA 286: 2120\u20132127, 2001.","journal-title":"JAMA"},{"key":"10200206_CR31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology 56: 1143\u20131153, 2001.","journal-title":"Neurology"},{"key":"10200206_CR32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.56.7.950","volume":"56","author":"W Jagust","year":"2001","unstructured":"Jagust W, Thisted R, Devous MD Sr, Van Heertum R, Mayberg H, Jobst K et al. SPECT perfusion imaging in the diagnosis of Alzheimer\u2019s disease: a clinical-pathologic study.Neurology 56: 950\u2013956, 2001.","journal-title":"Neurology"},{"key":"10200206_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","volume":"19","author":"Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association","year":"1998","unstructured":"Consensus report of the Working Group on: Molecular and biochemical markers of Alzheimer\u2019s disease. Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group.Neurobiol Aging 19: 109\u2013116, 1998.","journal-title":"Neurobiol Aging"},{"key":"10200206_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1532-5415.2003.51054.x","volume":"51","author":"MN Haan","year":"2003","unstructured":"Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.J Am Geriatr Soc 51: 169\u2013177, 2003.","journal-title":"J Am Geriatr Soc"},{"key":"10200206_CR35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/154.7.642","volume":"154","author":"C Helmer","year":"2001","unstructured":"Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF. Mortal with dementia: results from a French prospective community-based cohort.Am J Epidemiol 154: 642\u2013648, 2001.","journal-title":"Am J Epidemiol"},{"key":"10200206_CR36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-4580(92)90015-P","volume":"13","author":"R Mielke","year":"1991","unstructured":"Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.Neurobiol Aging 1991; 13: 93\u201398","journal-title":"Neurobiol Aging"},{"key":"10200206_CR37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0028-3932(87)90118-7","volume":"25","author":"CL Grady","year":"1987","unstructured":"Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI. Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type.Neuropsychologia 25: 807\u2013816, 1987.","journal-title":"Neuropsychologia"},{"key":"10200206_CR38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archpsyc.1989.01810060047008","volume":"46","author":"GW Small","year":"1989","unstructured":"Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter J et al. Cerebral glucose metabolic patterns in Alzheimer\u2019s disease: effect of gender and age at dementia onset.Arch Gen Psychiatry 46: 527\u2013532, 1989.","journal-title":"Arch Gen Psychiatry"},{"key":"10200206_CR39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jnnp.74.6.715","volume":"74","author":"PM Kemp","year":"2003","unstructured":"Kemp PM, Holmes C, Hoffmann SM, Bolt L, Holmes R, Rowden J, et al. Alzheimer\u2019s disease: differences in technetium-99m HM-PAO SPECT scan findings between early onset and late onset dementia.J Neurol Neurosurg Psychiatry 74: 715\u2013719, 2003.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10200206_CR40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jnnp.60.2.158","volume":"60","author":"C DeCarli","year":"1996","unstructured":"DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DGM et al. Comparison of positron emission tomography, cognition and brain volume in Alzheimer\u2019s disease with and without severe abnormalities of white matter.J Neurol Neurosurg Psychiatry 60: 158\u2013167, 1996.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10200206_CR41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410320311","volume":"32","author":"Y Stern","year":"1992","unstructured":"Stern Y, Alexander GE, Prohovnik I, Mayeux R. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer\u2019s disease.Ann Neurol 32: 371\u2013375, 1992.","journal-title":"Ann Neurol"},{"key":"10200206_CR42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.59.3.378","volume":"59","author":"WJ Jagust","year":"2002","unstructured":"Jagust WJ, Eberling JL, Wu CC, Finkbeiner A, Mungas D, Valk PE et al. Brain function and cognition in a community sample of elderly Latinos.Neurology 59: 378\u2013383, 2002.","journal-title":"Neurology"},{"key":"10200206_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-199706000-00002","volume":"11","author":"P Scheltens","year":"1997","unstructured":"Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single photon emission computed tomography for the diagnosis of Alzheimer\u2019s disease in a community dwelling elderly population.Alzheimer Dis Assoc Disord 11: 63\u201370, 1997.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10200206_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archneur.1995.00540270049018","volume":"52","author":"N Wolfe","year":"1995","unstructured":"Wolfe N, Reed BR, Eberling JL, Jagust WJ. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer\u2019s disease.Arch Neurol 52: 257\u2013262, 1995.","journal-title":"Arch Neurol"},{"key":"10200206_CR45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jon199663156","volume":"6","author":"WJ Jagust","year":"1996","unstructured":"Jagust WJ, Haan MN, Eberling JL, Wolfe N, Reed BR. Functional imaging predicts cognitive decline in Alzheimer\u2019s disease.J Neuroimaging 6: 156\u2013160, 1996.","journal-title":"J Neuroimaging"},{"key":"10200206_CR46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.51.4.1009","volume":"51","author":"WJ Jagust","year":"1998","unstructured":"Jagust WJ, Haan MN, Reed BR, Eberling JL. Brain perfusion imaging predicts survival in Alzheimer\u2019s disease.Neurology 51: 1009\u20131013, 1998.","journal-title":"Neurology"},{"key":"10200206_CR47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S et al. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the s4 allele for apolipoprotein E.N Engl J Med 334: 752\u2013758, 1996.","journal-title":"N Engl J Med"},{"key":"10200206_CR48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11270-7","volume":"186","author":"AM Kennedy","year":"1995","unstructured":"Kennedy AM, Frackowiak RSJ, Newman SK, Bloomfield PM, Seaward J, Roques P et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer\u2019s disease.Neurosci Lett 186: 17\u201320, 1995.","journal-title":"Neurosci Lett"},{"key":"10200206_CR49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome.Arch Neurol 56: 303\u2013308, 1999.","journal-title":"Arch Neurol"},{"key":"10200206_CR50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","volume":"22","author":"S Santi De","year":"2001","unstructured":"De Santi S, deLeon MJ, Rusinek H, Convit A, Tarshish C, Roche A et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD.Neurobiol Aging 22: 529\u2013539, 2001.","journal-title":"Neurobiol Aging"},{"key":"10200206_CR51","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ Leon de","year":"2001","unstructured":"de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/positron-emission tomography (FDG\/PET).Proc Natl Acad Sci USA 98: 10966\u201310971, 2001.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10200206_CR52","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","volume":"97","author":"GW Small","year":"2000","unstructured":"Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer\u2019s disease.Proc Natl Acad Sci USA 97: 6037\u20136042, 2000.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10200206_CR53","first-page":"851","volume":"12","author":"E Arnaiz","year":"2001","unstructured":"Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.Neuro-Report 12: 851\u2013855, 2001.","journal-title":"Neuro-Report"},{"key":"10200206_CR54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","volume":"60","author":"G Chetelat","year":"2003","unstructured":"Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease?Neurology 60: 1374\u20131377, 2003.","journal-title":"Neurology"},{"key":"10200206_CR55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00019442-200303000-00007","volume":"11","author":"L Tune","year":"2003","unstructured":"Tune L, Tiseo PJ, Ieni J, Perdomo C, Pratt RD, Votaw JR et al. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.Am J Geriatr Psychiatry 11: 169\u2013177, 2003.","journal-title":"Am J Geriatr Psychiatry"},{"key":"10200206_CR56","first-page":"63","volume":"14","author":"MS Mega","year":"2001","unstructured":"Mega MS, Cummings JL, O\u2019Connor SM, Dinov ID, Reback E, Felix J et al. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.Neuropsychiatry Neuropsychol Behav Neurol 14: 63\u201368, 2001.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10200206_CR57","first-page":"983","volume":"43","author":"F Nobili","year":"2002","unstructured":"Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K et al. Brain perfusion follow-up in Alzheimer\u2019s patients during treatment with acetylcholinesterase inhibitors.J Nucl Med 43: 983\u2013990, 2002.","journal-title":"J Nucl Med"},{"key":"10200206_CR58","first-page":"1441","volume":"42","author":"S Nakano","year":"2001","unstructured":"Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer\u2019s disease.J Nucl Med 42: 1441\u20131445, 2001.","journal-title":"J Nucl Med"},{"key":"10200206_CR59","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","volume":"98","author":"EM Reiman","year":"2001","unstructured":"Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease.Proc Natl Acad Sci USA 98: 3334\u20133339, 2001.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10200206_CR60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1532-5415.1997.tb02960.x","volume":"45","author":"LS Schneider","year":"1997","unstructured":"Schneider LS, Olin JT, Lyness SA, Chui HC. Eligibility of Alzheimer\u2019s disease clinic patients for clinical trials.J Am Geriatr Soc 45: 923\u2013928, 1997.","journal-title":"J Am Geriatr Soc"}],"container-title":["NeuroRX"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1602\/neurorx.1.2.206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T04:35:03Z","timestamp":1497587703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1602\/neurorx.1.2.206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10200206"],"URL":"https:\/\/doi.org\/10.1602\/neurorx.1.2.206","relation":{},"ISSN":["1545-5343"],"issn-type":[{"value":"1545-5343","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}